Inventor · disambiguated record
Robert J. Schwartz
Also filed as: SCHWARTZ ROBERT · SCHWARTZ ROBERT J · SCHWARTZ ROBERT JOEL
22 granted patents·11 pending applications·508 citations·filing 1991–2024
95Inventor score
Files withBAYLOR COLLEGE MEDICINE13UNIV HOUSTON SYSTEM6UNIV HOUSTON3ADVISYS INC2ANIMATUS BIOSCIENCES INC1
Top patents by PatentIndex Score
33 records- 0194US5298422AMyogenic vector systemsBAYLOR COLLEGE MEDICINE·Filed 1991·Granted Mar 29, 1994·173 cites·32 claims
- 0289US5756264AExpression vector systems and method of useBAYLOR COLLEGE MEDICINE·Filed 1994·Granted May 26, 1998·131 cites·26 claims
- 0387US6551996B1Super-active porcine growth hormone releasing hormone analogBAYLOR COLLEGE MEDICINE·Filed 2000·Granted Apr 22, 2003·34 cites·4 claims
- 0486US6423693B1Growth hormone releasing hormone expression system and methods of use, including use in animalsBAYLOR COLLEGE MEDICINE·Filed 1998·Granted Jul 23, 2002·46 cites·26 claims
- 0581US7960536B2Synthetic cell-or tissue-specific transcriptional regulatory regionsGENETRONICS INC·Filed 2005·Granted Jun 14, 2011·2 cites·4 claims
- 0680US7166461B2Polynucleotides encoding a super-active porcine growth hormone releasing hormone analogBAYLOR COLLEGE MEDICINE·Filed 2002·Granted Jan 23, 2007·15 cites·3 claims
- 0779US7338656B2Composition and method to alter lean body mass and bone properties in a subjectBAYLOR COLLEGE MEDICINE·Filed 2002·Granted Mar 4, 2008·11 cites·55 claims
- 0878US7241744B2Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormoneADVISYS INC·Filed 2002·Granted Jul 10, 2007·13 cites·1 claims
- 0971US2025018009A1Serum response factor regenerates senescent cellsUNIV HOUSTON SYSTEM·Filed 2024·Application pending·0 cites
- 1070US5374544AMutated skeletal actin promoterBAYLOR COLLEGE MEDICINE·Filed 1992·Granted Dec 20, 1994·43 cites·31 claims
- 1169US8486701B2ETS2 and MESP1 generate cardiac progenitors from fibroblastsSCHWARTZ ROBERT J·Filed 2011·Granted Jul 16, 2013·3 cites·3 claims
- 1264US2023304007A1Compositions and methods of treatment of muscle disorders by targeting h19x-encoded non-coding rnasUNIV HOUSTON SYSTEM·Filed 2023·Application pending·0 cites
- 1363US10300147B2Therapeutic miRNAs for treating heart and skeletal muscle diseasesUNIV HOUSTON SYSTEM·Filed 2017·Granted May 28, 2019·0 cites·13 claims
- 1462US5925564AExpression vector systems and method of useBAYLOR COLLEGE MEDICINE·Filed 1995·Granted Jul 20, 1999·25 cites·3 claims
- 1560US12042525B2Serum response factor regenerates senescent cellsUNIV HOUSTON SYSTEM·Filed 2018·Granted Jul 23, 2024·0 cites·19 claims
- 1660US9795690B2Therapeutic miRNAs for treating heart and skeletal muscle diseasesUNIV HOUSTON·Filed 2016·Granted Oct 24, 2017·0 cites·19 claims
- 1759US2023193267A1Cardiac cell proliferation by administering inhibitors of sav1, nf2, mob1 and/or mutant srfANIMATUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1858US7582478B2Cleaved serum response factor in cardiac diagnosis and therapyBAYLOR COLLEGE MEDICINE·Filed 2004·Granted Sep 1, 2009·0 cites·10 claims
- 1958US6410228B1Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regionsBAYLOR COLLEGE MEDICINE·Filed 1998·Granted Jun 25, 2002·11 cites·19 claims
- 2056US9439924B2Therapeutic miRNAs for treating heart and skeletal muscle diseasesUNIV HOUSTON·Filed 2015·Granted Sep 13, 2016·0 cites·10 claims
- 2156US8178504B2Gene therapy expression of GHRH for increasing RBC count in subjectsDRAGHIA-AKLI RUXANDRA·Filed 2007·Granted May 15, 2012·0 cites·10 claims
- 2256US2009292107A1Composition and method to alter lean body mass and bone properties in a subjectVGX PHARMACEUTICLAS INC·Filed 2008·Application pending·0 cites
- 2356US2003068631A1Method for the identification of synthetic cell-or tissue-specific transcriptional regulatory regionsBAYLOR COLLEGE MEDICINE·Filed 2002·Application pending·0 cites
- 2455US2024352422A1Direct reprogramming of cells into cardiac purkinje-like cells using a universal smallmolecule cocktailUNIV HOUSTON SYSTEM·Filed 2022·Application pending·0 cites
- 2554US9109232B2Ets2 and Mesp1 generate cardiac progenitors from fibroblastsUNIV HOUSTON·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 2653US2009293139A1Double-inducible gene activation system and its applicationsTEXAS A & M UNIV SYS·Filed 2009·Application pending·0 cites
- 2750US2006142193A1Selective inhibition of rock1 in cardiac therapyBAYLOR COLLEGE MEDICINE·Filed 2005·Application pending·0 cites
- 2850US2004175727A1Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cellsADVISYS INC·Filed 2003·Application pending·0 cites
- 2948US10335449B2Rho associated kinase (ROCK) inhibitors and their use in treating diseaseUNIV HOUSTON SYSTEM·Filed 2015·Granted Jul 2, 2019·0 cites·15 claims
- 3047US11179479B2Enhanced cardiomyocyte regenerationANIMATUS BIOSCIENCES LLC·Filed 2020·Granted Nov 23, 2021·0 cites·22 claims
- 3147US7811820B2Smooth muscle cell differentiation with CRP, SRF and GATA factorsBAYLOR COLLEGE MEDICINE·Filed 2004·Granted Oct 12, 2010·1 cites·15 claims
- 3245US2003055017A1Growth hormone releasing hormone expression system and methods of use, including use in animalsBAYLOR COLLEGE OF MEDICINE AND·Filed 2002·Application pending·0 cites
- 3344US2003074679A1Administration of nucleic acid sequence to female animal to enhance growth in offspringFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert J. Schwartz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →